BASE DOCUMENTAL DE LA ACTUALIZACIÓN MÉDICO-CONTINUADA EN CARDIOMIOPATÍA HIPERTRÓFICA ► Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)

Search Result Summary

CDC Resources

• CDC Web Information (0)
• CDC-Authored Genomics Publications (0)

Discoveries and Insights

• Hot Topics (3)
• Genomics & Health Impact Scan (1)
AMD Weekly Clips (0)
• Relevant Resources (2)

Epidemiology

• Human Genome Epidemiology (225)
• AMD Clips (0)
• Relevant Resources (1)

Translational Research

• Genomics & Health Impact Scan (11)
• AMD Weekly Clips (0)

Evidence Synthesis

• Guidelines (3)
• Evidence Classification (0)
• Genomics & Health Impact Scan (3)
• Relevant Resources (1)

Practice and Implementation

• Implementation (3)
• Genomics & Health Impact Scan (0)
• Relevant Resources (5)

What's New

Last Updated: Jan 13, 2016

• Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families.
  Lorca Rebeca et al. International journal of cardiology 2015 Dec 205161-162 (From Discoveries and Insights Database)
• Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
  Yaoita Masako, et al. Human genetics 2015 12 (From HuGE Literature Finder)
• Pennsylvania Genetic Services Program
  Disease: Multiple Diseases; Type: General Information; State: Pennsylvania (From Implementation Database)
• T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
  Hinojar Rocio, et al. Circulation. Cardiovascular imaging 2015 12 (12) (From HuGE Literature Finder)
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
  Maron Barry J et al. Circulation 2015 Dec 132(22) e273-80 (From Genomics & Health Impact Scan Database)
• Clinical implications of non sarcomeric gene polymorphisms in hypertrophic cardiomyopathy.
  García-Honrubia Antonio, et al. European journal of clinical investigation 2015 11 (From HuGE Literature Finder)
• Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.
  Damy Thibaud, et al. European heart journal 2015 11 (From HuGE Literature Finder)
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
  Maron Barry J et al. Journal of the American College of Cardiology 2015 Oct (From Genomics & Health Impact Scan Database)
• Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
  Ripoll-Vera Tomás, et al. Revista espanola de cardiologia (English ed.) 2015 10 (From HuGE Literature Finder)
• Too Young to Die: Impact of Sudden Cardiac Death of the Young in Michigan, 1999 - 2008[PDF 1.42 MB]
  Disease: Sudden Cardiac Death; Type: Data|Program; State: Michigan (From Implementation Database)
• Sudden Cardiac Death of the Young (SCDY) Surveillance and Prevention Project
  Disease: Sudden Cardiac Death; Type: Program; State: Michigan (From Implementation Database)
• Etiology and Programming Effects on Shock Efficacy in ICD Recipients.
  Bertomeu-Gonzalez Vicente, et al. Pacing and clinical electrophysiology : PACE 2015 10 (From HuGE Literature Finder)
• Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
  Carrozzo Rosalba, et al. Journal of inherited metabolic disease 2015 10 (From HuGE Literature Finder)
• Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
  Güçlü Ahmet, et al. European journal of clinical investigation 2015 10 (From HuGE Literature Finder)
• NOS1AP polymorphisms modify QTc interval duration but not cardiac arrest risk in hypertrophic cardiomyopathy.
  Earle Nikki, et al. Journal of cardiovascular electrophysiology 2015 9 (From HuGE Literature Finder)
• Association between angiotensinogen M235T polymorphism and hypertrophic cardiomyopathy.
  Yao Jia-Lu, et al. International journal of clinical and experimental medicine 2015 0 (6) 8767-75 (From HuGE Literature Finder)
• Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.
  Loar Robert W et al. Congenit Heart Dis 2015 Jun 10. (From Discoveries and Insights Database)
• Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
  Yagasaki Hideaki, et al. American journal of medical genetics. Part A 2015 8 (From HuGE Literature Finder)
• Clinical Application of WHF-MOGE(S) Classification for Hypertrophic Cardiomyopathy.
  Agarwal Anushree et al. Glob Heart 2015 Aug 11. (From Genomics & Health Impact Scan Database)
• Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population.
  Christensen Alex Hørby, et al. European journal of human genetics : EJHG 2015 8 (From HuGE Literature Finder)